Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Outline of a typology of men’s use of anabolic androgenic steroids in fitness and strength training environments*
Ask Vest Christiansen, Anders Vinther, Dimitris Liokaftos
Drugs Education Prevention and Policy (2016) Vol. 24, Iss. 3, pp. 295-305
Closed Access | Times Cited: 105

Showing 1-25 of 105 citing articles:

Identifying a typology of men who use anabolic androgenic steroids (AAS)
Renee Zahnow, Jim McVeigh, Geoff Bates, et al.
International Journal of Drug Policy (2018) Vol. 55, pp. 105-112
Open Access | Times Cited: 93
Anabolic-androgenic steroid use among women – A qualitative study on experiences of masculinizing, gonadal and sexual effects
Ingrid Amalia Havnes, Marie Lindvik Jørstad, Ingveig Innerdal, et al.
International Journal of Drug Policy (2020) Vol. 95, pp. 102876-102876
Open Access | Times Cited: 77
Beyond the law: Exploring the impact of criminalising anabolic–androgenic steroid use on help-seeking and health outcomes in Australia
Timothy Piatkowski, Nick Gibbs, Matthew Dunn
Journal of Criminology (2023) Vol. 57, Iss. 1, pp. 62-82
Open Access | Times Cited: 31
The Liver King Lie: Misrepresentation, justification, and public health implications
Nick Gibbs, Timothy Piatkowski
International Journal of Drug Policy (2023) Vol. 114, pp. 103979-103979
Open Access | Times Cited: 23
Mortality Among Users of Anabolic Steroids
Josefine Windfeld‐Mathiasen, Ida M. Heerfordt, Kim Dalhoff, et al.
JAMA (2024) Vol. 331, Iss. 14, pp. 1229-1229
Open Access | Times Cited: 12
Anything but androgens: How image and performance enhancing drug consumers manage body composition and health through off-label use of medicines
Timothy Piatkowski, Kim Akrigg, Luke Cox, et al.
Performance Enhancement & Health (2025), pp. 100329-100329
Open Access | Times Cited: 1
Support for people who use Anabolic Androgenic Steroids: A Systematic Scoping Review into what they want and what they access
Orlanda Harvey, Steve Keen, Margarete Parrish, et al.
BMC Public Health (2019) Vol. 19, Iss. 1
Open Access | Times Cited: 61
Anabolics coaching: Emic harm reduction or a public health concern?
Nick Gibbs, Luke Cox, Luke A. Turnock
Performance Enhancement & Health (2022) Vol. 10, Iss. 3, pp. 100227-100227
Open Access | Times Cited: 35
Click, click, buy: The market for novel synthetic peptide hormones on mainstream e-commerce platforms in the UK
Dr Luke Turnock, Nick Gibbs
Performance Enhancement & Health (2023) Vol. 11, Iss. 2, pp. 100251-100251
Open Access | Times Cited: 20
Polysubstance use practices among women using anabolic-androgenic steroids (AAS)
Timothy Piatkowski, Jonathan Robertson, Matthew Dunn
Performance Enhancement & Health (2023) Vol. 11, Iss. 2, pp. 100248-100248
Closed Access | Times Cited: 18
#Sponseredathlete: the marketing of image and performance enhancing drugs on Facebook and Instagram
Nick Gibbs
Trends in Organized Crime (2023)
Open Access | Times Cited: 18
Social media influencers, YouTube & performance and image enhancing drugs: A narrative-typology
Luke Cox, Letizia Paoli
Performance Enhancement & Health (2023) Vol. 11, Iss. 4, pp. 100266-100266
Open Access | Times Cited: 16
Androgen abuse: Risks and adverse effects in men
Bonnie Grant, Elizabeth Hyams, Rhianna Davies, et al.
Annals of the New York Academy of Sciences (2024) Vol. 1538, Iss. 1, pp. 56-70
Open Access | Times Cited: 7
What is the prevalence of anabolic‐androgenic steroid use among women? A systematic review
Timothy Piatkowski, Bianca Whiteside, Jonathan Robertson, et al.
Addiction (2024) Vol. 119, Iss. 12, pp. 2088-2100
Open Access | Times Cited: 7
Polydrug use and polydrug markets amongst image and performance enhancing drug users: Implications for harm reduction interventions and drug policy
Mike Salinas, William Floodgate, Robert Ralphs
International Journal of Drug Policy (2019) Vol. 67, pp. 43-51
Open Access | Times Cited: 49
“Yay, Another Lady Starting a Log!”: Women’s Fitness Doping and the Gendered Space of an Online Doping Forum
April Henning, Jesper Andreasson
Communication & Sport (2019) Vol. 9, Iss. 6, pp. 988-1007
Open Access | Times Cited: 49
Treatments for people who use anabolic androgenic steroids: a scoping review
Geoff Bates, Marie Claire Van Hout, Joseph Tay Wee Teck, et al.
Harm Reduction Journal (2019) Vol. 16, Iss. 1
Open Access | Times Cited: 43
Anabolic-Androgenic Steroid Use in Sports, Health, and Society
Shalender Bhasin, Disa L. Hatfield, Jay R. Hoffman, et al.
Medicine & Science in Sports & Exercise (2021) Vol. 53, Iss. 8, pp. 1778-1794
Open Access | Times Cited: 33
Anabolic-Androgenic Steroid Misuse: Mechanisms, Patterns of Misuse, User Typology, and Adverse Effects
Jack B. Ding, Marcus Z. Ng, Steven S. Huang, et al.
Journal of Sports Medicine (2021) Vol. 2021, pp. 1-9
Open Access | Times Cited: 33
Prevalence of anabolic steroid users seeking support from physicians: a systematic review and meta-analysis
Julio Mario Xerfan do Amaral, Andreas Kimergård, Paolo Deluca
BMJ Open (2022) Vol. 12, Iss. 7, pp. e056445-e056445
Open Access | Times Cited: 25
The new front in the war on doping: Amateur athletes
April Henning, Paul Dimeo
International Journal of Drug Policy (2017) Vol. 51, pp. 128-136
Open Access | Times Cited: 47
Health risk and health seeking behaviours among people who inject performance and image enhancing drugs who access needle syringe programs in Australia
Katinka van de Ven, Lisa Maher, Handan Wand, et al.
Drug and Alcohol Review (2018) Vol. 37, Iss. 7, pp. 837-846
Closed Access | Times Cited: 41
Steroid Madness- has the dark side of anabolic-androgenic steroids (AAS) been over-stated?
Kyle Mulrooney, Katinka van de Ven, Jim McVeigh, et al.
Performance Enhancement & Health (2019) Vol. 6, Iss. 3-4, pp. 98-102
Open Access | Times Cited: 36
The Anabolic Androgenic Steroid Treatment Gap: A National Study of Substance Use Disorder Treatment
Ingrid Amalia Havnes, Marie Lindvik Jørstad, Jim McVeigh, et al.
Substance Abuse Research and Treatment (2020) Vol. 14
Open Access | Times Cited: 36
The Association Between the Nonmedical use of Anabolic–Androgenic Steroids and Interpersonal Violence: A Meta-Analysis
Katinka van de Ven, John M. Malouff, Jim McVeigh
Trauma Violence & Abuse (2023) Vol. 25, Iss. 2, pp. 1484-1495
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top